European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team.

IF 2 4区医学 Q3 ONCOLOGY

Tumori Pub Date : 2025-02-01 Epub Date: 2024-12-06 DOI:10.1177/03008916241303022

Cristiana Sessa, Luzia Travado, Gabriele Calaminus, Teresa Margarida Cunha, Roberto C Delgado Bolton, Willemien van Driel, Andreia Fernandes, Margaret Hutka, Birthe Lemley, Natalia Luczak, Rui Medeiros, Simon Oberst, Nelleke Ottevanger, Andrea Papadia, Philippe Pereira, Manuel Rodrigues, Simona Stolnicu, Katrien Vandecasteele, Alberto Costa, Philip Poortmans, Fedro Peccatori

{"title":"European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team.","authors":"Cristiana Sessa, Luzia Travado, Gabriele Calaminus, Teresa Margarida Cunha, Roberto C Delgado Bolton, Willemien van Driel, Andreia Fernandes, Margaret Hutka, Birthe Lemley, Natalia Luczak, Rui Medeiros, Simon Oberst, Nelleke Ottevanger, Andrea Papadia, Philippe Pereira, Manuel Rodrigues, Simona Stolnicu, Katrien Vandecasteele, Alberto Costa, Philip Poortmans, Fedro Peccatori","doi":"10.1177/03008916241303022","DOIUrl":null,"url":null,"abstract":"<p><p>European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care. Here, the essential requirements to treat ovarian cancer patients are described. Ovarian cancer patients continue to have low cure rates with wide variation in treatment and care in Europe and beyond. They require complex treatment that should be carried out in specialised ovarian/gynaecological cancer centres by professionals with the appropriate expertise interacting in a multidisciplinary team. Such centralisation is still not well established in many European countries. A patient-centred pathway from diagnosis through treatment to survivorship, managed in dedicated centres, is key to achieving optimal care and a successful clinical outcome.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":" ","pages":"11-19"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916241303022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care. Here, the essential requirements to treat ovarian cancer patients are described. Ovarian cancer patients continue to have low cure rates with wide variation in treatment and care in Europe and beyond. They require complex treatment that should be carried out in specialised ovarian/gynaecological cancer centres by professionals with the appropriate expertise interacting in a multidisciplinary team. Such centralisation is still not well established in many European countries. A patient-centred pathway from diagnosis through treatment to survivorship, managed in dedicated centres, is key to achieving optimal care and a successful clinical outcome.

查看原文本刊更多论文

欧洲癌症组织对卵巢癌质量癌症护理的基本要求：关注多学科团队。

欧洲癌症组织质量癌症护理基本要求（ERQCC）是由代表欧洲癌症护理所有学科的专家撰写的。它们为患者、卫生专业人员、管理人员和政策制定者提供了基本护理指南。在这里，描述了治疗卵巢癌患者的基本要求。在欧洲和其他地区，卵巢癌患者的治愈率仍然很低，治疗和护理的差异很大。它们需要复杂的治疗，应在专门的卵巢/妇科癌症中心由具有适当专业知识的专业人员在多学科团队中相互作用进行治疗。这种集中化在许多欧洲国家还没有很好地建立起来。以患者为中心的从诊断到治疗到生存的途径，在专门的中心进行管理，是实现最佳护理和成功临床结果的关键。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Tumori 医学-肿瘤学

CiteScore

3.50

自引率

0.00%

发文量

审稿时长

6 months

期刊介绍： Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.